Determination of Ceruloplasmin in Human Serum by Immunoaffinity Chromatography and Size-Exclusion Chromatography-ICP-MS

Applications | 2017 | Agilent TechnologiesInstrumentation
GPC/SEC, ICP/MS
Industries
Clinical Research
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

HANDBOOK OF HYPHENATED ICP-MS APPLICATIONS - 2nd Edition
Human Serum and Plasma Protein Depletion – Novel High-Capacity Affinity Column for the Removal of the “Top 14” Abundant Proteins
Simultaneous determination of try acid in pretreated human blood
Development of a Hybrid Immunoaffinity-LC-MS/MS Method for the Quantification of Active Biotherapeutics Targeting TNF-α in Serum